Role of natural killer cells in defense against leukemia: therapeutic considerations.
Lotzová
E
E
Department of General Surgery, University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, Houston.
D003602:Cytotoxicity, Immunologic; D006801:Humans; D007116:Immunization, Passive; D007167:Immunotherapy; D066298:In Vitro Techniques; D007376:Interleukin-2 / Q000627:therapeutic use; D007694:Killer Cells, Natural / Q000276:immunology*; D007938:Leukemia / Q000276:immunology / Q000628:therapy*
D007376:Interleukin-2